开云app官网登录入口网页版-官方正版

#镭-223#

9篇内容 | 1016人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2198549, encodeId=dc372198549fd, content=<a href='/topic/show?id=b0f49684898' target=_blank style='color:#2F92EE;'>#镭-223#</a> <a href='/topic/show?id=34b54848271' target=_blank style='color:#2F92EE;'>#帕博利珠单抗#</a> <a href='/topic/show?id=a17393408d0' target=_blank style='color:#2F92EE;'>#转移性去势抵抗性前列腺癌#</a>, objectTitle=Cancer Immunol | 帕博利珠单抗与镭-223联合治疗转移性去势抵抗性前列腺癌的随机II期研究, objectType=article, longId=821655, objectId=4d818216558d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/03c6505b36012caf29ea7e5b6940b3e7a9fd349b.jpg, objectUrl=/article/show_article.do?id=4d818216558d, replyNumber=0, likeNumber=83, createdTime=2024-04-15, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4d818216558d, moduleTitle=Cancer Immunol | 帕博利珠单抗与镭-223联合治疗转移性去势抵抗性前列腺癌的随机II期研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4d818216558d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1929008, encodeId=267f192900855, content=<a href='/topic/show?id=b0f49684898' target=_blank style='color:#2F92EE;'>#镭-223#</a>, objectTitle=Clin Cancer Res：遗憾！阿特珠单抗+镭-223联合方案未能给mCRPC患者带来额外的临床效益, objectType=article, longId=216703, objectId=fd7e216e0320, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd7e216e0320, replyNumber=0, likeNumber=74, createdTime=2022-06-04, rootId=0, userName=songbq, userId=856b247, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd7e216e0320, moduleTitle=Clin Cancer Res：遗憾！阿特珠单抗+镭-223联合方案未能给mCRPC患者带来额外的临床效益, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=fd7e216e0320)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1929007, encodeId=f209192900ed1, content=<a href='/topic/show?id=b0f49684898' target=_blank style='color:#2F92EE;'>#镭-223#</a>, objectTitle=Prostate：镭-223和阿比特龙或恩扎鲁胺在现实世界人群中同时治疗的安全性 , objectType=article, longId=209036, objectId=aeea20903638, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aeea20903638, replyNumber=0, likeNumber=74, createdTime=2021-09-28, rootId=0, userName=songbq, userId=856b247, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aeea20903638, moduleTitle=Prostate：镭-223和阿比特龙或恩扎鲁胺在现实世界人群中同时治疗的安全性 , moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=aeea20903638)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1929006, encodeId=8f6e19290063b, content=<a href='/topic/show?id=b0f49684898' target=_blank style='color:#2F92EE;'>#镭-223#</a>, objectTitle=Prostate Cancer P D：镭-223治疗去势抵抗性前列腺癌研究 , objectType=article, longId=200059, objectId=62c6200059f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62c6200059f7, replyNumber=0, likeNumber=81, createdTime=2021-03-25, rootId=0, userName=songbq, userId=856b247, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62c6200059f7, moduleTitle=Prostate Cancer P D：镭-223治疗去势抵抗性前列腺癌研究 , moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=62c6200059f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1929005, encodeId=57c719290052d, content=<a href='/topic/show?id=b0f49684898' target=_blank style='color:#2F92EE;'>#镭-223#</a>, objectTitle=Prostate Cancer P D：镭-223和恩杂鲁胺或阿比特龙/强的松同时或分层治疗转移去势抵抗性前列腺癌, objectType=article, longId=195245, objectId=a2df19524559, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2df19524559, replyNumber=0, likeNumber=77, createdTime=2020-09-15, rootId=0, userName=songbq, userId=856b247, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2df19524559, moduleTitle=Prostate Cancer P D：镭-223和恩杂鲁胺或阿比特龙/强的松同时或分层治疗转移去势抵抗性前列腺癌, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a2df19524559)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1929004, encodeId=16cc19290041f, content=<a href='/topic/show?id=b0f49684898' target=_blank style='color:#2F92EE;'>#镭-223#</a>, objectTitle=Cancer Med：二氯化镭-223联合激素治疗激素受体阳性骨转移性乳腺癌的II期研究, objectType=article, longId=192853, objectId=22aa1928533a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22aa1928533a, replyNumber=0, likeNumber=123, createdTime=2021-03-03, rootId=0, userName=songbq, userId=856b247, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22aa1928533a, moduleTitle=Cancer Med：二氯化镭-223联合激素治疗激素受体阳性骨转移性乳腺癌的II期研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=22aa1928533a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1929002, encodeId=1be319290020e, content=<a href='/topic/show?id=b0f49684898' target=_blank style='color:#2F92EE;'>#镭-223#</a>, objectTitle=Cancer Manag Res：骨扫描能够指导二氯化镭-223治疗前列腺癌骨转移么？, objectType=article, longId=149886, objectId=2fee149886ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fee149886ed, replyNumber=0, likeNumber=64, createdTime=2019-05-24, rootId=0, userName=songbq, userId=856b247, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fee149886ed, moduleTitle=Cancer Manag Res：骨扫描能够指导二氯化镭-223治疗前列腺癌骨转移么？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2fee149886ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1929003, encodeId=a91e1929003b4, content=<a href='/topic/show?id=b0f49684898' target=_blank style='color:#2F92EE;'>#镭-223#</a>, objectTitle=Lancet oncol：醋酸阿比特龙联合镭-223不能延长去势耐受性前列腺癌骨转移患者的无症状骨骼事件存活期, objectType=article, longId=159655, objectId=7e6a15965554, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e6a15965554, replyNumber=0, likeNumber=84, createdTime=2019-09-18, rootId=0, userName=songbq, userId=856b247, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e6a15965554, moduleTitle=Lancet oncol：醋酸阿比特龙联合镭-223不能延长去势耐受性前列腺癌骨转移患者的无症状骨骼事件存活期, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7e6a15965554)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1929001, encodeId=95df19290010a, content=<a href='/topic/show?id=b0f49684898' target=_blank style='color:#2F92EE;'>#镭-223#</a>, objectTitle=Lancet Oncol：镭-223辅助治疗前列腺癌, objectType=article, longId=77101, objectId=9097e710161, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9097e710161, replyNumber=0, likeNumber=67, createdTime=2016-12-07, rootId=0, userName=songbq, userId=856b247, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9097e710161, moduleTitle=Lancet Oncol：镭-223辅助治疗前列腺癌, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9097e710161)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1929000, encodeId=4b35192900097, content=<a href='/topic/show?id=b0f49684898' target=_blank style='color:#2F92EE;'>#镭-223#</a>, objectTitle=NEJM：镭-223可显著改善骨转移前列腺癌的总生存率, objectType=article, longId=22064, objectId=e59f2206429, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e59f2206429, replyNumber=0, likeNumber=70, createdTime=2013-10-17, rootId=0, userName=songbq, userId=856b247, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e59f2206429, moduleTitle=NEJM：镭-223可显著改善骨转移前列腺癌的总生存率, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e59f2206429)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

镭-223

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#镭-223# #帕博利珠单抗# #转移性去势抵抗性前列腺癌#

Cancer Immunol | 帕博利珠单抗与镭-223联合治疗转移性去势抵抗性前列腺癌的随机II期研究

2024-04-15发表于上海

songbq (审核中...)

前往app查看评论内容

#镭-223#

Clin Cancer Res：遗憾！阿特珠单抗+镭-223联合方案未能给mCRPC患者带来额外的临床效益

2022-06-04

songbq (审核中...)

前往app查看评论内容

#镭-223#

Prostate：镭-223和阿比特龙或恩扎鲁胺在现实世界人群中同时治疗的安全性

2021-09-28

songbq (审核中...)

前往app查看评论内容

#镭-223#

Prostate Cancer P D：镭-223治疗去势抵抗性前列腺癌研究

2021-03-25

songbq (审核中...)

前往app查看评论内容

#镭-223#

Prostate Cancer P D：镭-223和恩杂鲁胺或阿比特龙/强的松同时或分层治疗转移去势抵抗性前列腺癌

2020-09-15

songbq (审核中...)

前往app查看评论内容

#镭-223#

Cancer Med：二氯化镭-223联合激素治疗激素受体阳性骨转移性乳腺癌的II期研究

2021-03-03

songbq (审核中...)

前往app查看评论内容

#镭-223#

Cancer Manag Res：骨扫描能够指导二氯化镭-223治疗前列腺癌骨转移么？

2019-05-24

songbq (审核中...)

前往app查看评论内容

#镭-223#

Lancet oncol：醋酸阿比特龙联合镭-223不能延长去势耐受性前列腺癌骨转移患者的无症状骨骼事件存活期

2019-09-18

songbq (审核中...)

前往app查看评论内容

#镭-223#

Lancet Oncol：镭-223辅助治疗前列腺癌

2016-12-07

songbq (审核中...)

前往app查看评论内容

#镭-223#

NEJM：镭-223可显著改善骨转移前列腺癌的总生存率

2013-10-17

科室
- - 订阅+
  - 更多科室
工具
服务